Biologics have revolutionized – and are revolutionizing – the treatment of many serious disorders. The evidence acquired from more than 10 years of clinical experience, with more than 50 biosimilar drugs and more than 700 million patient-days’ exposure in Europe, shows that approved biosimilars can be used as safely and effectively as originator biologics. Yet concerns persist about biosimilars – particularly in curative cancer treatment, where they are relatively recent therapeutic options. ‘Fast Facts: Biosimilars in Hematology and Oncology’ provides a concise overview of emerging global practice in this fast-moving area together with practical information on adding biosimilars to a formulary and switching patients.
Compre este e-book e ganhe mais 1 GRÁTIS!
Língua Inglês ● Formato EPUB ● Páginas 128 ● ISBN 9781912776221 ● Tamanho do arquivo 5.5 MB ● Editora S. Karger AG ● Cidade Basel ● País CH ● Publicado 2020 ● Edição 1 ● Carregável 24 meses ● Moeda EUR ● ID 7729225 ● Proteção contra cópia Adobe DRM
Requer um leitor de ebook capaz de DRM